PCR London Valves 2025

17 Nov 2025

TAVI

Planning a lifetime of care in younger patients with Evolut FX+: from index valve to future options

Sponsored by Medtronic

Anchorperson: N. Van Mieghem

Spokesperson: G. Tarantini

SHOW MORE

Summary

Watch this PCR London Valves 2025 session to take a deep look at the latest evidence in low-risk aortic stenosis, the durability of contemporary valves, and how anatomy — especially in women and patients with small annuli — shapes long-term strategy.

From index TAVI with Evolut FX+ to future interventions, the discussion unpacks what truly influences outcomes over decades, including the feasibility and nuances of redo-TAVI.

Learning Objectives

To explore the latest evidence concerning low-risk patients with aortic stenosis, long-term outcomes, valve durability, and specific considerations for women and patients with small annular anatomy
To master strategies for lifetime management and learn how to address key challenges in managing patients with prolonged life expectancy (including the feasibility of redo-TAVI)
To appreciate innovative TAVI techniques and technologies, and understand their role in improving clinical outcomes in diverse patient populations

N. Van Mieghem

Speaker

Welcome and session objectives

Download presentation

Giuseppe Tarantini

Speaker

Patient presentation

Download presentation

N. Van Mieghem

Speaker

Operator strategy

Download presentation

Speaker

Procedural analysis

Download presentation

Giuseppe Tarantini

Speaker

Session evaluation and key learnings

Download presentation